Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2015 1
2016 2
2017 1
2019 1
2020 4
2021 4
2022 6
2023 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Zhang X, et al. Among authors: e jy. Lancet Oncol. 2021 Aug;22(8):1081-1092. doi: 10.1016/S1470-2045(21)00297-7. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252374 Clinical Trial.
INTERPRETATION: Perioperative-SOX showed a clinically meaningful improvement compared with adjuvant-CapOx in patients with locally advanced gastric cancer who had D2 gastrectomy; adjuvant-SOX was non-inferior to adjuvant-CapOx in these patients. Perioperative-SOX could be conside …
INTERPRETATION: Perioperative-SOX showed a clinically meaningful improvement compared with adjuvant-CapOx in patients with locally advanced …
Tubular-specific expression of HIV protein Vpr leads to severe tubulointerstitial damage accompanied by progressive fibrosis and cystic development.
Chen Y, Chen Y, Fu J, Sun Z, Li H, Xiao W, E J, Lo BY, Wang N, Zhang W, Klotman ME, Klotman PE, Kopp JB, D'Agati VD, He JC, Lee K. Chen Y, et al. Among authors: e j. Kidney Int. 2023 Mar;103(3):529-543. doi: 10.1016/j.kint.2022.12.012. Epub 2022 Dec 22. Kidney Int. 2023. PMID: 36565808 Free PMC article.
Thus, our study demonstrates that HIV Vpr expression in tubular cells is sufficient to induce HIVAN-like tubulointerstitial damage and fibrosis, independent of glomerulosclerosis and proteinuria. Additionally, as this new mouse model develops progressive CKD with diffuse f …
Thus, our study demonstrates that HIV Vpr expression in tubular cells is sufficient to induce HIVAN-like tubulointerstitial damage and fibro …
Tubular HIPK2 is a key contributor to renal fibrosis.
Xiao W, E J, Bao L, Fan Y, Jin Y, Wang A, Bauman D, Li Z, Zheng YL, Liu R, Lee K, He JC. Xiao W, et al. Among authors: e j. JCI Insight. 2020 Sep 3;5(17):e136004. doi: 10.1172/jci.insight.136004. JCI Insight. 2020. PMID: 32701510 Free PMC article.
Kosakonia radicincitans with hypervirulent lON genes causes human bloodstream infections.
Chen Z, Tang L, Yuan C, E J, Wang D, Liu X, Zheng M, Xiao H, Jiang S. Chen Z, et al. Among authors: e j. Future Microbiol. 2023 Apr;18:317-322. doi: 10.2217/fmb-2022-0190. Epub 2023 May 4. Future Microbiol. 2023. PMID: 37140352
Kosakonia radicincitans is a species within the new genus Kosakonia, which is typically a plant pathogen, with rare reports of human infection. The number of human infections may be underestimated because this new genus is under-represented among diagnostic tools. T …
Kosakonia radicincitans is a species within the new genus Kosakonia, which is typically a plant pathogen, with rare reports of human …
Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy.
He ZX, Zhao SB, Fang X, E JF, Fu HY, Song YH, Wu JY, Pan P, Gu L, Xia T, Liu YL, Li ZS, Wang SL, Bai Y. He ZX, et al. Among authors: e jf. Front Oncol. 2022 Jan 11;11:761030. doi: 10.3389/fonc.2021.761030. eCollection 2021. Front Oncol. 2022. PMID: 35096572 Free PMC article.
Exploring the tumor-immune interactions in the tumor microenvironment and identifying new prognostic and therapeutic biomarkers will assist in decoding the novel mechanism of tumor immunotherapy. ...
Exploring the tumor-immune interactions in the tumor microenvironment and identifying new prognostic and therapeutic biomarkers will …
A new species of Pristerophora Harold, 1869 (Coleoptera: Scarabaeidae: Melolonthinae) from Chile.
E JM. E JM. Zootaxa. 2024 Apr 9;5433(4):588-594. doi: 10.11646/zootaxa.5433.4.8. Zootaxa. 2024. PMID: 39646751
A new species of Macrodactylini (Coleoptera: Scarabaeidae: Melolonthinae), Pristerophora rothmanni new species, is described and illustrated based on male and female specimens collected in southern Chile. ...
A new species of Macrodactylini (Coleoptera: Scarabaeidae: Melolonthinae), Pristerophora rothmanni new species, is described a …
Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment.
E JY, Li T, McInally L, Thomson K, Shahani U, Gray L, Howe TE, Skelton DA. E JY, et al. Cochrane Database Syst Rev. 2020 Sep 3;9(9):CD009233. doi: 10.1002/14651858.CD009233.pub3. Cochrane Database Syst Rev. 2020. PMID: 32885841 Free PMC article.
MAIN RESULTS: We included six RCTs (686 participants) conducted in five countries (Australia, Hungary, New Zealand, UK, US) with follow-up periods ranging from two to 12 months. Participants in these trials included older adults (mean age 80 years) and were mostly female ( …
MAIN RESULTS: We included six RCTs (686 participants) conducted in five countries (Australia, Hungary, New Zealand, UK, US) with foll …
Molecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19.
Kallingal A, Thachan Kundil V, Ayyolath A, Karlapudi AP, Muringayil Joseph T, E JV. Kallingal A, et al. Among authors: e jv. J Biomol Struct Dyn. 2022 Mar;40(4):1764-1775. doi: 10.1080/07391102.2020.1832580. Epub 2020 Oct 9. J Biomol Struct Dyn. 2022. PMID: 33036548
But, the race of researchers for developing new and effective antiviral to stop the disease progression still continues and our work is one among them. ...
But, the race of researchers for developing new and effective antiviral to stop the disease progression still continues and our work …
20 results